Maxim Group Sticks to Its Buy Rating for Hain Celestial

By Austin Angelo

In a report released today, Anthony Vendetti from Maxim Group reiterated a Buy rating on Hain Celestial (NASDAQ: HAIN), with a price target of $50. The company’s shares opened today at $42.99.

Vendetti observed:

“F4Q17 (Jun) total adjusted net sales of $725.1M, up 2.1% y/y on a constant currency basis, was relatively inline with our estimate of $725.0M, but slightly above consensus of $719.5M.”

According to, Vendetti is a 4-star analyst with an average return of 11.1% and a 54.9% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Xtant Medical Holdings, Milestone Scientific, and Syneron Medical Ltd.

Hain Celestial has an analyst consensus of Hold, with a price target consensus of $42.40.

Based on Hain Celestial’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $707 million and quarterly net profit of $31.33 million. In comparison, last year the company earned revenue of $738 million and had a GAAP net loss of $88.6 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Hain Celestial Group, Inc. engages in the production and distribution of organic and natural products. It offers products grocery, snacks, tea, personal care, and poultry.